News about us
Recent articles that mention MVI
(Click on headline to read the full story.)
Areas with low malaria rates 'need mass vaccination'
January 25, 2012 – The most promising malaria vaccine candidate should be rolled out through mass vaccination campaigns—rather than the WHO's routine infant vaccinations—in parts of Africa with low malaria transmission, says a study.
SciDev.Net
The remarkable journey of the RTS,S vaccine
January 12, 2012 – It is no easy task following over 15,000 children across 11 sites, two in Ghana (Agogo and Kintampo) and the rest in Kenya, Mozambique, Tanzania, Malawi, Burkina Faso and Gabon in a Phase 3 RTS,S vaccine trials, described as the largest malarial clinical trials in Africa.
Graphic Ghana
New vaccine could help end malaria
January 11, 2012 –
The tropical disease kills more people annually than cancer, but researchers think they can win the fight.
Al Jazeera
Unique whole parasite malaria vaccine shows promise during school of medicine clinical trial
December 15, 2011 –
For the first time, a malaria vaccine that uses the entire malaria parasite has proven safe and shown promise to produce a strong immune response in a clinical trial, according to a new study co-authored by researchers at the Center for Vaccine Development at the School of Medicine.
University of Maryland's VOICE
McDermott statement on malaria vaccine, Seattle’s involvement, and Time Magazine’s designation
December 8, 2011 – Congressman Jim McDermott (D-WA) issued the below statement following Time magazine's article that a major advance toward the first-ever malaria vaccine was among the top 10 Medical Breakthroughs of 2011. The trial malaria vaccine was developed through the efforts of two Seattle-based organizations—PATH and the Bill & Melinda Gates Foundation—as well as GlaxoSmithKline.
Press release from
Congressman Jim McDermott
A First-Ever Malaria Vaccine
December 7, 2011 – A first-ever malaria vaccine tested in children in sub-Saharan Africa cut the risk of infection with malaria by about half
— a remarkable achievement, considering there has never been a vaccine against a human parasite before, or against malaria, which infects millions of children each year.
TIME Magazine
Malaria vaccine to get human trial
December 6, 2011 – Three U.S. health institutions say they've joined to evaluate a potential vaccine designed to prevent transmission of malaria from mosquitoes to humans.
United Press International
Coast medics impressed by new malaria vaccine
December 2, 2011 – Communities from malaria endemic regions of Kenya are excited about the potential of a malaria vaccine, a study conducted in two malaria-endemic regions of coastal and Western Kenya shows.
www.coastweek.com
Quarter-century quest for malaria vaccine shows signs of success
December 2011 –
The long development of RTS,S, the leading malaria vaccine candidate, has yielded preliminary positive Phase III results, and laid a path for future success.
Nature
Malaria vaccine making headway, but don't forget your meds, experts say
November 17, 2011 – A vaccination against malaria may soon be available for children in Africa, but travelers to malaria endemic areas will have to wait much longer for such protection.
Medill Reports
Profectus BioSciences awarded follow-on grant from PATH Malaria Vaccine Initiative (MVI)
November 15, 2011 – Profectus BioSciences, Inc. (Profectus), a leader in the development of therapeutic and preventive vaccines against infectious diseases and cancers, announced today it has received a commitment of additional funding from the PATH Malaria Vaccine Initiative (MVI).
Reuters
Malaria vaccine trialled
October 19, 2011 –
Millions of children’s lives could be saved by a new vaccine shown to halve the risk of malaria in the first large-scale trial across seven African countries,” reported The Guardian.
NHS Choices
Breakthrough malaria vaccine tantalizingly close
October 19, 2011 – A malaria vaccine has eluded scientists for decades, but preliminary results from a phase 3 clinical trial in Africa are providing hope. The data suggest that the vaccine, known as RTS,S, cuts the number of malaria cases in half.
CNN
Experimental malaria vaccine protects many children, study shows
October 18, 2011 – For the first time, an experimental vaccine has been shown to safely protect large numbers of children against malaria, one of the world’s most devastating scourges and one that has long evaded medicine’s most potent weapons.
The Washington Post
Malaria vaccine could save millions of children's lives
October 18, 2011 –
Millions of small children's lives could be saved by a new vaccine that has been shown to halve the risk of malaria in the first large-scale trials across seven African countries.
The Guardian
Malaria vaccine prevents about half of cases in children
October 18, 2011 –
A malaria vaccine under development has passed a critical milestone with researchers reporting Tuesday that the shots protect about half of all children from the disease.
Los Angeles Times
Experimental malaria vaccine slashes infection risk by half
October 18, 2011 –
After decades of disappointment, researchers think they're finally on track to unleash the first practical vaccine against malaria, one of mankind's ancient scourges. In the world's first large field trial of an experimental malaria vaccine, several thousand young children who got three doses had about 55 percent less risk of getting the disease over a year than those who got a control vaccine against rabies or meningitis.
NPR
Malaria vaccine shows promise, scientists say
October 18, 2011 –
Preliminary results from the trial of a malaria vaccine show that it protected nearly half of the children who received it from bouts of serious malaria, scientists said Tuesday.
The New York Times
Malaria scientist celebrates success after 24 years
October 18, 2011 –
For Joe Cohen, a GlaxoSmithKline research scientist who has spent 24 years trying to create the world's first malaria vaccine, Tuesday, October 18, 2011 goes down as a fabulous day.
Reuters
Powering clinical trials
August 1, 2011 –
To ensure high-quality clinical trials of a malaria vaccine, organizers in rural Africa must first upgrade electrical and research infrastructures.
The Scientist
Malaria – on the long, slow but steady road to elimination
June 28, 2011 –
Amid all the gloomy talk of economic recession and dire warnings that the amount of money available for development aid is going to shrink, a report on the state of malaria research out on Tuesday is refreshingly upbeat. Investment has more than quadrupled in the past 16 years, it says, from $121m in 1993 to $612m in 2009.
The Guardian
AFRICA: Malaria vaccine could have extra benefits
June 20, 2011 –
The malaria vaccine that has eluded medical science for decades is now within reach, with the final phase of clinical trials underway in seven African countries, including Malawi, where the disease claims 6,500 lives a year, most of them children under the age of five.
IRIN
Initiative to develop second-generation malaria vaccine
June 7, 2011 –
The PATH Malaria Vaccine Initiative (MVI) announces that it has entered into a collaboration with Dutch biopharmaceutical company Crucell N.V. and GlaxoSmithKline (GSK). This collaboration is aimed at developing a second-generation vaccine against malaria — a deadly disease that kills close to 800,000 people annually, most of them young children under age 5 in Africa.
Infection Control Today
GSK, J&J to trial next-generation malaria vaccine
June 6, 2011 – Even as the world's first malaria vaccine gets closer to the market, two leading drug firms have joined forces to test a next-generation shot against the mosquito-borne disease that kills 800,000 people a year.
Reuters
Leading global health groups call on US to accelerate research
May 3, 2011 – A coalition of 30 leading global health organizations that work on vaccines, drugs, and other tools and technologies that save lives today released a list of recommendations for US policymakers and regulators, calling for acceleration of scientific innovations and streamlining the approval of safe and affordable inventions in order to save more lives around the world.
PhysOrg.com
Building on vaccine achievements, agency and partners ramp up to immunize 4 million
April/May 2011 – USAID, along with other US government health agencies and international health organizations, was behind the global program to eliminate smallpox and bring the power of life saving vaccines to millions of the world’s poor. The Agency is continuing to strengthen vaccination programs and is supporting scientists and researchers who are trying to find the latest miracle shot that will make today’s most deadly and burdensome diseases a distant memory.
USAID FrontLines
Advancing against malaria
April 29, 2011 –
Progress against malaria is one area where US investments in global health have made an incredible impact. Just five years ago, it was estimated that malaria killed nearly one million children annually in sub-Saharan Africa. The economic cost to the continent was estimated to be nearly $30 billion each year in lost productivity.
Voice of America
Interview: Dr. John Lusingu talks about malaria vaccine trials in Tanzania
April 25, 2011 –
After speaking with Dr. Loucq about the exciting development of the malaria vaccine through the PATH Malaria Vaccine Initiative (MVI), we were thrilled to talk to Dr. John Lusingu, a malaria vaccine researcher at an MVI trial site in Tanzania. Dr. Lusingu discussed the devastating impact of malaria in his community and ongoing research on the ground.
ONE blog
Interview: Dr. Christian Loucq discusses his life-long passion for vaccines
April 25, 2011 –
We were delighted when Dr. Christian Loucq, director of the PATH Malaria Vaccine Initiative stopped by the ONE office last week for an interview in honor of World Malaria Day. He candidly shared his experiences from around the world and his thoughts on vaccines, advocacy and the future of the fight against malaria.
ONE blog
African scientists move against malaria
April 25, 2011 –
Malaria is not something we usually celebrate. It is something we overcome. Day in and day out, too many of us struggle against its insidious threat to our children. As scientists studying ways to defeat malaria, we witness the toll all too often. However, on this World Malaria Day, while reflecting on the burden of the disease, we should pause to celebrate the strides made in the fight against it.
The Citizen
Vaccines: Partnerships boost success hopes
April 21, 2011 –
The world’s first large-scale clinical trial of a malaria vaccine has just completed enrolment.
In seven African countries, 15,640 babies and young children are receiving the so-called RTS,S vaccine being developed by GlaxoSmithKline in a public-private partnership with the PATH Malaria Vaccine Initiative (MVI).
Financial Times
World Malaria Day: African researchers on the move against malaria
April 19, 2011 –
Malaria is not something we usually celebrate. It is something we overcome. Day in and day out, too many of us struggle against its insidious threat to our children. As scientists studying ways to defeat malaria, we witness the toll all too often.
Modern Ghana
The Silent Killer
April 18, 2011 –
The EU must honor its development commitments and invest in the global fight against malaria, writes Michele Striffler.
Parliament Magazine
Liquidia Technologies and PATH Malaria Vaccine Initiative collaborate
February 8, 2011 – Liquidia Technologies today announced a collaboration with the PATH Malaria Vaccine Initiative (MVI) to explore the use of the company’s PRINT® particle technology to design next-generation malaria vaccines. PRINT technology offers unprecedented control of particle size, shape and chemistry in a highly consistent and scalable manufacturing process, and will be used to deliver a protein in combination with immune stimulating molecules.
Genetic Engineering & Biotechnology News
